14
Aug
Mumbai (Maharashtra) [India], August 14: For Shukra Pharmaceuticals Limited, Friday’s listing on the National Stock Exchange was not simply a new milestone in its capital markets journey. It was a moment to look at what 33 years of building trust can make possible next. As the listing bell rang at the NSE, the company’s leadership spoke of a Shukra that is carrying its pharmaceutical foundation into a much wider healthcare and technology landscape, one shaped increasingly by artificial intelligence, robotics, advanced medical devices and new frontiers of medical innovation. Addressing the gathering, Dakshesh Shah, Chairman & Managing Director, Shukra Pharmaceuticals…